A*STAR Bioprocessing Technology Institute (A*STAR BTI)

Researchers from A*STAR explain how defects in a signaling protein sabotage the immune system in multiple, seemingly contradictory ways

A single enzyme plays a critical role in helping the body effectively fight viral infection

The latest microfluidic chip can generate microbubbles to break open cells for biochemical analysis

MicroRNAs are essential for B-cell development and antibody production

Identification of a signaling pathway could aid development of stem cell-based therapies for Parkinson’s disease

Fibroblast growth factor-2 keeps stems cells in their undifferentiated state by activating Wnt signaling

Tyrosine phosphorylation profiles illuminate the molecular basis of self-renewal in human embryonic stem cells

Chinese hamster ovary and baby hamster kidney cell lines are the best choices for producing therapeutic glycoprotein that stays in the bloodstream longer

A new bioprocessing system enables large-scale production of heart muscle cells from stem cells

Efficient production of glycoprotein drugs to treat anemia and other disorders comes a step closer via genetic engineering

An evaluation study shows that more efficient cell-sorting methods are needed to make stem cell-derived tissues sufficiently safe for transplantation

An antibody that selectively kills off undifferentiated stem cells may improve their clinical usefulness